Survival of bactericidal antibiotic treatment by tolerant persister cells of Klebsiella pneumoniae

Purpose. Persister cells, a subpopulation of tolerant cells within the bacterial culture, are commonly thought to be responsible for antibiotic therapy failure and infection recurrence. Klebsiella pneumoniae is a notorious human pathogen for its increasing resistance to antibiotics and wide involvement in severe infections. In this study, we aimed to investigate the persister subpopulation of K. pneumoniae. Methodology. The presence of persisters in K. pneumoniae was determined by treatment with high concentrations of antibiotics, used alone or in combination. The effect of low level of antibiotics on persister formation was investigated by pre‐exposure of cells to antibiotics with low concentrations followed by higher doses. The dependence of persister levels on growth phase was determined by measuring the survival ability of cells along the growth stages upon exposure to a high concentration of antibiotic. Analysis on persister type was carried out by persister elimination assays. Results/Key findings. We show that K. pneumoniae produces high levels of tolerant persister cells to survive treatment by a variety of high concentrations of bactericidal antibiotics and persister formation is prevalent among K. pneumoniae clinical strains. Besides, we find that persister cells can be induced by low concentrations of antibiotics. Finally, we provide evidence that persister formation is growth phase‐dependent and Type II persisters dominate the persister subpopulation during the entire exponential phase of K. pneumoniae. Conclusion. Our study describes the formation of tolerant persister cells that allow survival of treatment by high concentrations of antibiotics in K. pneumoniae.

[1]  C. A. Ferreira,et al.  Combination of polymyxin B and meropenem eradicates persister cells from Acinetobacter baumannii strains in exponential growth. , 2017, Journal of medical microbiology.

[2]  Anna D. Tischler,et al.  Mycobacterium tuberculosis PhoY Proteins Promote Persister Formation by Mediating Pst/SenX3-RegX3 Phosphate Sensing , 2017, mBio.

[3]  R. Fisher,et al.  Persistent bacterial infections and persister cells , 2017, Nature Reviews Microbiology.

[4]  Jan Michiels,et al.  Formation, physiology, ecology, evolution and clinical importance of bacterial persisters. , 2017, FEMS microbiology reviews.

[5]  Alessandra Carattoli,et al.  Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance , 2017, FEMS microbiology reviews.

[6]  Joel S. Freundlich,et al.  Enhanced respiration prevents drug tolerance and drug resistance in Mycobacterium tuberculosis , 2017, Proceedings of the National Academy of Sciences.

[7]  N. Shoresh,et al.  Antibiotic tolerance facilitates the evolution of resistance , 2017, Science.

[8]  K. Lewis,et al.  ATP-Dependent Persister Formation in Escherichia coli , 2017, mBio.

[9]  Neang S. Ly,et al.  Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes. , 2017, International journal of antimicrobial agents.

[10]  Y. Li,et al.  A TolC-Like Protein of Actinobacillus pleuropneumoniae Is Involved in Antibiotic Resistance and Biofilm Formation , 2016, Front. Microbiol..

[11]  Y. Liu,et al.  HigB of Pseudomonas aeruginosa Enhances Killing of Phagocytes by Up-Regulating the Type III Secretion System in Ciprofloxacin Induced Persister Cells , 2016, Front. Cell. Infect. Microbiol..

[12]  J. Mecsas,et al.  Klebsiella pneumoniae: Going on the Offense with a Strong Defense , 2016, Microbiology and Molecular Reviews.

[13]  N. Verstraeten,et al.  In Vitro Emergence of High Persistence upon Periodic Aminoglycoside Challenge in the ESKAPE Pathogens , 2016, Antimicrobial Agents and Chemotherapy.

[14]  Ofer Fridman,et al.  Distinguishing between resistance, tolerance and persistence to antibiotic treatment , 2016, Nature Reviews Microbiology.

[15]  Joshua N. Adkins,et al.  Persister formation in Staphylococcus aureus is associated with ATP depletion , 2016, Nature Microbiology.

[16]  X. Zou,et al.  Gradual increase in antibiotic concentration affects persistence of Klebsiella pneumoniae. , 2015, The Journal of antimicrobial chemotherapy.

[17]  Martin Ackermann,et al.  A functional perspective on phenotypic heterogeneity in microorganisms , 2015, Nature Reviews Microbiology.

[18]  J. Mckinney,et al.  Stress and host immunity amplify Mycobacterium tuberculosis phenotypic heterogeneity and induce nongrowing metabolically active forms. , 2015, Cell host & microbe.

[19]  M. Webber,et al.  Molecular mechanisms of antibiotic resistance , 2014, Nature Reviews Microbiology.

[20]  Dongsheng Zhou,et al.  Molecular pathogenesis of Klebsiella pneumoniae. , 2014, Future microbiology.

[21]  G. Donelli,et al.  Antibiotic Resistance Related to Biofilm Formation in Klebsiella pneumoniae , 2014, Pathogens.

[22]  Heleen Van Acker,et al.  Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms. , 2014, Trends in microbiology.

[23]  R. Bertram,et al.  Characterization of multi-drug tolerant persister cells in Streptococcus suis , 2014, BMC Microbiology.

[24]  K. Gerdes,et al.  Molecular Mechanisms Underlying Bacterial Persisters , 2014, Cell.

[25]  B. Kreiswirth,et al.  Doripenem, Gentamicin, and Colistin, Alone and in Combinations, against Gentamicin-Susceptible, KPC-Producing Klebsiella pneumoniae Strains with Various ompK36 Genotypes , 2014, Antimicrobial Agents and Chemotherapy.

[26]  S. Rice,et al.  Mannitol Enhances Antibiotic Sensitivity of Persister Bacteria in Pseudomonas aeruginosa Biofilms , 2013, PloS one.

[27]  L. Gram,et al.  Survival of Bactericidal Antibiotic Treatment by a Persister Subpopulation of Listeria monocytogenes , 2013, Applied and Environmental Microbiology.

[28]  J. Collins,et al.  Microbial persistence and the road to drug resistance. , 2013, Cell host & microbe.

[29]  T. Russo,et al.  Hypervirulent (hypermucoviscous) Klebsiella pneumoniae , 2013, Virulence.

[30]  N. Verstraeten,et al.  New-found fundamentals of bacterial persistence. , 2012, Trends in microbiology.

[31]  M. Barer,et al.  Targeting Persisters for Tuberculosis Control , 2012, Antimicrobial Agents and Chemotherapy.

[32]  Jan Michiels,et al.  Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies. , 2011, Journal of medical microbiology.

[33]  S. Lory,et al.  Emergence of Pseudomonas aeruginosa Strains Producing High Levels of Persister Cells in Patients with Cystic Fibrosis , 2010, Journal of bacteriology.

[34]  C. Dean,et al.  Pseudomonas aeruginosa Increases Formation of Multidrug-Tolerant Persister Cells in Response to Quorum-Sensing Signaling Molecules , 2010, Journal of bacteriology.

[35]  J. Mckinney,et al.  Microbial phenotypic heterogeneity and antibiotic tolerance. , 2007, Current opinion in microbiology.

[36]  K. Lewis,et al.  Specialized Persister Cells and the Mechanism of Multidrug Tolerance in Escherichia coli , 2004, Journal of bacteriology.

[37]  S. Leibler,et al.  Bacterial Persistence as a Phenotypic Switch , 2004, Science.

[38]  H. Chou,et al.  Isolation of a Chromosomal Region of Klebsiella pneumoniae Associated with Allantoin Metabolism and Liver Infection , 2004, Infection and Immunity.

[39]  J. Oliver,et al.  Bridging the gap between viable but non-culturable and antibiotic persistent bacteria. , 2015, Trends in microbiology.